Klimaksan homeopathic tablets blister pack No. 20

Instructions for use Klimaksan homeopathic tablets blister pack No. 20

Composition

active ingredients: 1 tablet contains Cimicifuga C200 – 0.8 mg, Lachesis C50 – 0.8 mg, Apis C200 – 0.8 mg;

excipients: lactose monohydrate, microcrystalline cellulose, magnesium stearate.

Dosage form

Pills.

Main physicochemical properties: flat-cylindrical tablets with a bevel, white or almost white in color.

Pharmacotherapeutic group

A complex homeopathic preparation.

Pharmacological properties

Pharmacodynamics

The drug eliminates vegetative-vascular disorders caused by hormonal imbalance, which is characteristic of the premenstrual and menopausal periods. It has a moderate sedative effect.

Indication

It is used as a symptomatic remedy in the treatment of manifestations of climacteric syndrome (irritability, emotional lability, sleep disturbances, headache, dizziness, palpitations, increased sweating, hot flashes).

Contraindication

Increased individual sensitivity to the components of the drug; pregnancy and breastfeeding.

Interaction with other medicinal products and other types of interactions

No cases of incompatibility with other drugs have been registered.

If necessary, the drug can be used in combination with other agents.

Application features

The drug contains lactose, therefore it is not recommended for use in patients with congenital galactosemia, glucose or galactose malabsorption syndrome, and congenital lactase deficiency.

Patients with diabetes should remember that 1 tablet of the drug contains 0.2136 g of lactose, which corresponds to 0.018 bread units (BSU). The maximum daily dose of the drug is 4 tablets, which corresponds to 0.072 BSU.

During the course of treatment with the drug, it is recommended to consult a doctor at least once every 2 months for the purpose of possible correction of therapy.

When taking homeopathic medicines, a temporary exacerbation of existing symptoms (primary aggravation) is possible. In this case, you should stop taking the medicine and consult a doctor.

Ability to influence reaction speed when driving vehicles or other mechanisms

There is no data on the effect on reaction speed, so the drug should be taken with caution.

Use during pregnancy or breastfeeding

The drug is contraindicated for use in women during pregnancy and breastfeeding.

Method of administration and doses

The drug is taken orally. A single dose is 1 tablet. The tablet is kept in the mouth (without chewing or swallowing) until completely dissolved.

The drug is taken daily 2 times a day, in the morning and in the evening.

In severe cases of menopause, the number of doses may be increased to 3–4 times a day.

The recommended duration of treatment with the drug is 1–2 months.

If necessary, the course of treatment can be repeated after 2–3 weeks.

Children

The drug is not used in children.

Overdose

In case of accidental overdose, dyspeptic manifestations caused by the components included in the drug are possible.

Adverse reactions

Reactions of increased individual sensitivity to the components of the drug are possible.

Expiration date

3 years.

Do not use the drug after the expiration date indicated on the package.

Storage conditions

Store at a temperature not exceeding 25 ° C. Keep out of the reach of children.

Packaging

20 tablets in a blister; 1 blister in a cardboard box.

Vacation category

Without a prescription.

Producer

Santonica CJSC.

Location of the manufacturer and its business address

St. Waveryu 134B, Kaunas, Kaunas sam., LT-46353, Lithuania.